NCT04373694

Brief Summary

This study is a randomized controlled trial take place in a fertility outpatient clinic in an academic hospital. Women between 18 and 52 years old requiring polypectomy or myomectomy by hysteroscopy morcellation for abnormal uterine bleeding or for fertility issue are included. The aim is to evaluate pain perception between vaginal and traditional hysteroscopy for hysteroscopic morcellation. The investigator's hypothesis is that pain perception is lower using vaginoscopy compared to traditional hysteroscopy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 4, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

September 9, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 12, 2023

Status Verified

January 1, 2023

Enrollment Period

3.3 years

First QC Date

April 23, 2020

Last Update Submit

January 11, 2023

Conditions

Keywords

vaginoscopyhysteroscopy morcellationinfertile population

Outcome Measures

Primary Outcomes (1)

  • Difference in pain perception between vaginoscopy group and traditional hysteroscopy group

    10 point visual analog pain scale: 0 for no pain to 10 for unbearable pain

    immediately after intervention

Secondary Outcomes (5)

  • Difference in length of time of procedure between vaginoscopy group and traditional hysteroscopy group

    immediately after intervention

  • Difference in proportion of vasovagal syncope between vaginoscopy group and traditional hysteroscopy group

    immediately after surgery

  • Difference in proportion of uterine perforation between vaginoscopy group and traditional hysteroscopy group

    immediatly after surgery

  • Difference in length of time to continue fertility treatment between vaginoscopy group and traditional hysteroscopy group

    up to 1 year

  • Difference in length of time to pregnancy between vaginoscopy group and traditional hysteroscopy group

    up to 1 year

Study Arms (2)

Standard hysteroscopy

ACTIVE COMPARATOR

morcellation hysteroscopy with intravenous sedation and paracervical bloc

Procedure: standard hysteroscopy

Vaginoscopy

EXPERIMENTAL

morcellation hysteroscopy with only intravenous sedation

Procedure: vaginoscopy

Interventions

vaginoscopyPROCEDURE

vaginal distension with hysteroscope for hysteroscopy morcellation (without speculum or tenaculum forceps)

Vaginoscopy

speculum, paracervical block before hysteroscopy morcellation

Standard hysteroscopy

Eligibility Criteria

Age18 Years - 52 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • polyp or fibroid previously diagnosed by hysteroscopy
  • polyp less than 2 cm
  • submucosal fibroid (type 0 or 1 according to the 2011 FIGO uterine fibroid classification) less than 2 cm
  • if more than 1 fibroid: total fibroid have to be less or equal 4 cm

You may not qualify if:

  • cervical stenosis
  • polyp or fibroid more than 2 cm
  • pregnancy
  • blood dyscrasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHUM - Clinique Médecine et biologie de la reproduction

Montreal, Quebec, H2X 1P1, Canada

Location

MeSH Terms

Conditions

Myofibroma

Condition Hierarchy (Ancestors)

Neoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Carole KAMGA-NGANDE, MD

    Centre hospitalier de l'Université de Montréal (CHUM)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2020

First Posted

May 4, 2020

Study Start

September 9, 2020

Primary Completion

December 31, 2023

Study Completion

December 31, 2024

Last Updated

January 12, 2023

Record last verified: 2023-01

Locations